Authors
Loading...
Retrospective cohort study shows neoadjuvant chemoradiation improves survival in rectal cancer, highlighting pCR and carcinoembryonic antigen as vital factors.
Ghalehtaki et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: